Kaisa Health Group Holdings Limited (0876.HK)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HKD m | 184 | 210 | 191 | 186 | 185 | 139 | 354 | - |
| Operating profit | HKD m | -55 | -68 | ||||||
| Net profit | HKD m | -40 | 2 | -123 | 7 | -46 | -47 | -98 | - |
| EPS reported | HKD | -23.00 | -18.51 | ||||||
| Operating cashflow per share | HKD | -23.46 | -0.01 | ||||||
| Capex per share | HKD | 5.50 | 0.00 | ||||||
| FCF per share | HKD | -28.96 | -0.01 | ||||||
| Free cash flow | HKD m | -58 | -56 | ||||||
| Net debt | HKD m | -110 | 617 | ||||||
| Book value equity | HKD m | 403 | -323 | ||||||
| Book value per share | HKD | 200.0 | -0.07 | ||||||
| Number of shares | m | 2.02 | 4,850.09 | ||||||
| DPS (TTM paid) | HKD | 0.00 | 0.00 |
Financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.02 | -0.02 | ||||||
| P/S LTM | x | 0.05 | 0.02 | ||||||
| P/FCF LTM | x | -0.12 | -0.13 | ||||||
| EV/EBITDA LTM | x | 1.84 | 2.40 | ||||||
| EV/Sales LTM | x | -0.64 | 2.30 | ||||||
| Earnings Yield LTM | % | -6.61% | -1.03% | ||||||
| FCF Yield | % | -827.45% | -796.33% | ||||||
| Quality | |||||||||
| ROE | % | -11.57% | -242.50% | ||||||
| ROIC | % | -13.43% | -11.67% | ||||||
| Operating margin | % | -39.82% | -19.34% | ||||||
| Gross margin | % | +36.41% | +37.64% | ||||||
| FCF/Sales | % | -41.99% | -15.87% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -24.95% | +91.05% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -4.34 | -0.09 | ||||||
| Net Debt/EBITDA | x | 1.99 | -16.61 | ||||||
| EBIT/Net interest | x | -93.57 | -5.94 | ||||||
| Net debt/market cap | % | 0.00% | +2.08% | ||||||
| Net debt/Equity | x | -0.27 | -1.91 | ||||||
| Gross debt/equity | x | 0.03 | -2.01 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products. The company was formerly known as Mega Medical Technology Limited and changed its name to Kaisa Health Group Holdings Limited in January 2018. Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered in Central, Hong Kong.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Kaisa Health Group Holdings Limited (0876.HK)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products. The company was formerly known as Mega Medical Technology Limited and changed its name to Kaisa Health Group Holdings Limited in January 2018. Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered in Central, Hong Kong.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free